Upfront Therapy of Acute Myeloid Leukemia
Upfront Therapy of Acute Myeloid Leukemia
About this item
Full title
Author / Creator
Publisher
New York: Current Science Inc
Journal title
Language
English
Formats
Publication information
Publisher
New York: Current Science Inc
Subjects
More information
Scope and Contents
Contents
Acute myeloid leukemia is a clinically and biologically heterogeneous disease. Standard induction chemotherapy, consisting of cytarabine and an anthracycline, has not changed substantially over several decades, and outcomes remain suboptimal, particularly in older patients. Many genetic and molecular changes have been identified that guide selectio...
Alternative Titles
Full title
Upfront Therapy of Acute Myeloid Leukemia
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_887508059
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_887508059
Other Identifiers
ISSN
1523-3790
E-ISSN
1534-6269
DOI
10.1007/s11912-011-0184-x
